Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child.
Severe hypoglycaemia developed seven months after a bone marrow transplantation in a child with severe combined immunodeficiency. His serum exerted potent insulin-like activity: (a) it stimulated insulin receptor autophosphorylation and kinase activity in cell-free systems, this effect being additive to insulin; (b) it increased glucose transport in isolated soleus muscle. These insulin-like effects were due to immunoglobulins against the insulin receptor. Indeed, the patient serum immunoprecipitated human or murine insulin receptors from different tissues and inhibited insulin binding to receptor on human IM-9 lymphocytes. After corticoids and immunosuppressive therapy by azathioprine, the patient hypoglycaemic episodes disappeared, and concomitantly, the antibodies to insulin receptor were no longer detected, as judged by both immunoprecipitation of insulin receptor and stimulation of glucose transport.
Rochet
N
N
INSERM U145, Faculté de Médecine, Nice, France.
Blanche
S
S
Carel
J C
JC
Fischer
A
A
Deist
F L
FL
Griscelli
C
C
Van Obberghen
E
E
Le Marchand-Brustel
Y
Y
D000818:Animals; D000917:Antibody Formation; D001323:Autoantibodies / Q000096:biosynthesis*; D016026:Bone Marrow Transplantation; D002460:Cell Line; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology / Q000276:immunology*; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000276:immunology* / Q000628:therapy; D007223:Infant; D007700:Kinetics; D008297:Male; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D051381:Rats; D011972:Receptor, Insulin / Q000276:immunology* / Q000378:metabolism
D001323:Autoantibodies; D011505:Protein-Tyrosine Kinases; D011972:Receptor, Insulin